跳至主要内容
临床试验/CTRI/2020/03/024001
CTRI/2020/03/024001尚未招募2 期

Efficacy of Zarawand in Hyperuricemia: A Randomized Standard Controlled Study.

ATIONAL INSTITUTE OF UNANI MEDICINE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients Uric acid >6 mg/dl
  • eGFR >90ml/min/1.73m2

排除标准

  • Pregnant and lactating mothers
  • Diabetes Mellitus, Poorly controlled hypertension
  • Blood pressure >=160/100
  • Significant liver or Renal dysfunction
  • cardiovascular diseases
  • A Medical condition that in the investigators opinion would interfere with the treatment, safety, or adherence to the protocol

研究者

发起方
ATIONAL INSTITUTE OF UNANI MEDICINE

相似试验